Peter Saliba-Gustafsson

8PUBLICATIONS
38CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Ngā pūnaha whakahaere mōhiohio me te mātauranga o te Māori (Māori information and knowledge management systems)Metabolic medicineGene mappingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 27, 2025
Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver Disease.

Peter Saliba-Gustafsson, Jennifer Härdfeldt, Matteo Pedrelli

|Nov 19, 2024
Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease.

Osman Ahmed, Vladimir S Shavva, Laura Tarnawski

|Aug 27, 2024
A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes.

Peter Saliba-Gustafsson, Johanne M Justesen, Amanda Ranta

|Feb 14, 2024
A functional genomic framework to elucidate novel causal non-alcoholic fatty liver disease genes.

Peter Saliba-Gustafsson, Johanne M Justesen, Amanda Ranta

|Jun 25, 2022
The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.

Miguel Carracedo, Sven-Christian Pawelzik, Gonzalo Artiach

|Mar 24, 2022
Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis.

Urszula Rykaczewska, Quanyi Zhao, Peter Saliba-Gustafsson

Pageof 2